Sun Pharma gets nod from South African regulator for generic semaglutide injection

The approval by the SAHPRA is to manufacture and market the generic version of semaglutide injection in South Africa for the treatment of adults with inadequately controlled type 2 diabetes mellitus as an adjunct to diet and exercise, says Sun Pharmaceutical Industries